iso-sulfan blue has been researched along with Atypical Ductal Hyperplasia in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (70.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cora, C; Deisch, J; Garberoglio, C; Garberoglio, R; Lum, SS; Olaya, W; Pairawan, SS; Senthil, M; Solomon, N | 1 |
Chung, A; Cody, H; Montgomery, L; Patil, S; Stempel, M; Yu, J | 1 |
Cox, CE; Kaur, P; Kiluk, JV; Laronga, C; Meade, T; Ramos, D; Santillan, AA | 1 |
Babiera, GV; Bedrosian, I; Hunt, KK; Hwang, RF; Kang, T; Kuerer, H; Lucci, A; Meric-Bernstam, F; Mittendorf, EA; Yi, M | 1 |
Afshari, S; Gur, I; Kilkenny, JW | 1 |
Chao, C; McMasters, K | 1 |
Blanchard, DK; Donohue, JH; Grant, CS; Reynolds, C | 1 |
Chua, B; Davis, N; Donald, JC; Hayashi, AH; Olivotto, IA; Rusnak, CH | 1 |
Chang, AE; Cimmino, VM; Degnim, AC; Diehl, KM; Newman, LA; Oh, K; Sabel, MS | 1 |
Bold, RJ; Fahy, BN; Schlieman, M | 1 |
2 review(s) available for iso-sulfan blue and Atypical Ductal Hyperplasia
Article | Year |
---|---|
The current status of sentinel lymph node biopsy for breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Lymph Node Excision; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2002 |
Sentinel lymph node biopsy for breast cancer.
Topics: Aged; Axilla; Bibliometrics; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Coloring Agents; Contraindications; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Mastectomy; Middle Aged; Neoplasm Staging; Patient Care Team; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2001 |
1 trial(s) available for iso-sulfan blue and Atypical Ductal Hyperplasia
Article | Year |
---|---|
Percutaneous Sentinel Node Biopsy in Breast Cancer: Results of a Phase 1 Study.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Large-Core Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Coloring Agents; Female; Humans; Image-Guided Biopsy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid; Ultrasonography | 2016 |
7 other study(ies) available for iso-sulfan blue and Atypical Ductal Hyperplasia
Article | Year |
---|---|
Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Coloring Agents; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2008 |
Feasibility of sentinel lymph node biopsy through an inframammary incision for a nipple-sparing mastectomy.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Feasibility Studies; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Morbidity; Neoplasm Invasiveness; Neoplasm Staging; Nipples; Postoperative Care; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Treatment Outcome | 2008 |
Does blue dye contribute to success of sentinel node mapping for breast cancer?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Coloring Agents; Female; Humans; Lymph Nodes; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Young Adult | 2010 |
Sudden false oxygen desaturation and factitious methemoglobinemia after subcutaneous injection of isosulfan blue (lymphazurin).
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Cyanosis; Factitious Disorders; Female; Humans; Methemoglobinemia; Middle Aged; Oximetry; Rosaniline Dyes | 2011 |
Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Immunohistochemistry; Logistic Models; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Middle Aged; Morbidity; Neoplasm Recurrence, Local; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2003 |
Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia.
Topics: Breast Neoplasms; British Columbia; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Practice Patterns, Physicians'; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2003 |
Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
Topics: Axilla; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Humans; Lymph Nodes; Male; Radionuclide Imaging; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2005 |